LivaNova (LIVN) Net Income towards Common Stockholders Growth (1y) (2015 - 2026)
Powered by 
Analysis
LivaNova (LIVN) Net Income towards Common Stockholders Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.92% |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 300.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300.03% |
| Mar 31, 2026 | 107.07% |
| Dec 31, 2025 | -44.69% |
| Sep 30, 2025 | -18.59% |
| Jun 30, 2025 | 66.05% |
| Mar 31, 2025 | -680.83% |
| Dec 31, 2024 | 241.72% |
| Sep 30, 2024 | 551.77% |
| Jun 30, 2024 | 1,283.09% |
| Mar 31, 2024 | -666.68% |
| Dec 31, 2023 | 867.81% |
| Sep 30, 2023 | 93.22% |
| Jun 30, 2023 | -92.82% |
| Mar 31, 2023 | 143.96% |
| Dec 31, 2022 | 133.22% |
| Sep 30, 2022 | -147.38% |
| Jun 30, 2022 | 129.21% |
| Mar 31, 2022 | 109.87% |
| Dec 31, 2021 | 98.21% |
| Sep 30, 2021 | -194.86% |